Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.

PubMed  Google Scholar 

Huang HL, Leung CY, Saito E, Katanoda K, Hur C, Kong CY, et al. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study. BMC Med. 2020;18(1):257.

PubMed  PubMed Central  Google Scholar 

Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, et al. A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment: a multi-phase study. Am J Gastroenterol. 2017;112(5):704–15.

PubMed  Google Scholar 

Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87.

PubMed  Google Scholar 

Braga Emidio N, Brierley SM, Schroeder CI, Muttenthaler M. Structure, function, and therapeutic potential of the trefoil factor family in the gastrointestinal tract. ACS Pharmacol Transl Sci. 2020;3(4):583–97.

CAS  PubMed  PubMed Central  Google Scholar 

Hoffmann W. TFF2, a MUC6-binding lectin stabilizing the gastric mucus barrier and more (Review). Int J Oncol. 2015;47(3):806–16.

CAS  PubMed  Google Scholar 

Cai Y, Yi M, Chen D, Liu J, Guleng B, Ren J, et al. Trefoil factor family 2 expression inhibits gastric cancer cell growth and invasion in vitro via interactions with the transcription factor Sp3. Int J Mol Med. 2016;38(5):1474–80.

CAS  PubMed  PubMed Central  Google Scholar 

Kaise M, Miwa J, Tashiro J, Ohmoto Y, Morimoto S, Kato M, et al. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk. J Gastroenterol. 2011;46(6):736–45.

CAS  PubMed  Google Scholar 

Aikou S, Ohmoto Y, Gunji T, Matsuhashi N, Ohtsu H, Miura H, et al. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology. 2011;141(3):837-845.e1.

CAS  PubMed  Google Scholar 

Huang Z, Zhang X, Lu H, Wu L, Wang D, Zhang Q, et al. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China. BMC Gastroenterol. 2014;14:74.

PubMed  PubMed Central  Google Scholar 

Zan X, Chen Z, Guo Q, Wang Y, Zhang Z, Ji R, et al. The association of trefoil factors with gastric cancer and premalignant lesions: a cross-sectional population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2022;31(3):625–32.

CAS  PubMed  Google Scholar 

Ji R, Zhang Z, Zhang J, Wu Z, Li M, Ye Y, et al. Cohort Profile: a population-based cohort for the study of gastric cancer in northwest area of China (Wuwei Cohort). Int J Epidemiol. 2021;50(5):1433–42.

PubMed  Google Scholar 

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.

PubMed  Google Scholar 

Li CY, Ye YC, Liang GY, Zhang WH, Zhang ZY, Liu XQ, et al. Cancer incidence and mortality survey in Wuwei, Gansu Province, Northwestern China from 2003 to 2012: a retrospective population-based study. Chin Med J (Engl). 2016;129(6):636–44.

PubMed  Google Scholar 

Liu Y, Zhang X, Chen L, Zhao Q, Xia X. Cancer incidence and mortality in Gansu province, 2012. Chin J Cancer Res. 2016;28(3):301–10.

PubMed  PubMed Central  Google Scholar 

T. B. F, H. H. R, D. T. N. WHO Classification of Tumours of the Digestive System. World Health Organization.

Pohl H, Wrobel K, Bojarski C, Voderholzer W, Sonnenberg A, Rösch T, et al. Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol. 2013;108(2):200–7.

PubMed  Google Scholar 

Kjellev S. The trefoil factor family - small peptides with multiple functionalities. Cell Mol Life Sci. 2009;66(8):1350–69.

CAS  PubMed  Google Scholar 

Chong Y, Yu D, Lu Z, Nie F. Role and research progress of spasmolytic polypeptide-expressing metaplasia in gastric cancer (Review). Int J Oncol. 2024;64(3):33.

CAS  PubMed  PubMed Central  Google Scholar 

Ge Y, Ma G, Liu H, Lin Y, Zhang G, Du M, et al. MUC1 is associated with TFF2 methylation in gastric cancer. Clin Epigenet. 2020;12(1):37.

CAS  Google Scholar 

Peterson AJ, Menheniott TR, O’Connor L, Walduck AK, Fox JG, Kawakami K, et al. Helicobacter pylori infection promotes methylation and silencing of Trefoil Factor 2, leading to gastric tumor development in mice and humans. Gastroenterology. 2010;139(6):2005–17.

CAS  PubMed  Google Scholar 

Masumoto Y, Matsuo S, Kinjou N, Narieda Y, Wada M, Fujimoto K. The expression of trefoil factor family member 2 in increased at an acidic pH. Oncol Lett. 2024;27(5):1–9.

Google Scholar 

Hernández C, Santamatilde E, McCreath K, Cervera A, Díez I, Ortiz-Masiá D, et al. Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing. Br J Pharmacol. 2009;156(2):262–72.

PubMed  Google Scholar 

Hu GY, Yu BP, Dong WG, Li MQ, Yu JP, Luo HS, et al. Expression of TFF2 and Helicobacter pylori infection in carcinogenesis of gastric mucosa. World J Gastroenterol. 2003;9(5):910–4.

CAS  PubMed  PubMed Central  Google Scholar 

Goldenring JR, Nam KT, Wang TC, Mills JC, Wright NA. Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer. Gastroenterology. 2010;138(7):2207-2210.e1.

PubMed  Google Scholar 

Berman AG, Tan WK, O’Donovan M, Markowetz F, Fitzgerald RC. Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett’s oesophagus by machine learning. EBioMedicine. 2022;82: 104160.

CAS  PubMed  PubMed Central  Google Scholar 

Fitzgerald RC, di Pietro M, O’Donovan M, Maroni R, Muldrew B, Debiram-Beecham I, et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett’s oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial. Lancet. 2020;396(10247):333–44.

PubMed  PubMed Central  Google Scholar 

Cai Q, Zhu C, Yuan Y, Feng Q, Feng Y, Hao Y, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68(9):1576–87.

CAS  PubMed  Google Scholar 

Kishikawa H, Kimura K, Takarabe S, Kaida S, Nishida J. Helicobacter pylori antibody titer and gastric cancer screening. Dis Markers. 2015;2015: 156719.

PubMed  PubMed Central  Google Scholar